Freitag Gregory Gene's Form 4 filing
Axogen, Inc. (AXGN) · filed Aug 8, 2022
- Accession no.
- 0000805928-22-000105
- Filed
- Aug 8, 2022
- Trade date
- Aug 4-8, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $390.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Freitag Gregory GeneCIK 0001492710 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2022 | Common Stock | SSaleDisposed | −24,000 | $10.64 | −$255,360 | 387,515 | Direct | |
| Aug 8, 2022 | Common Stock | SSaleDisposed | −13,046 | $10.37 | −$135,287.02 | 374,469 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.